Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines

The development of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands for the treatment of diseases including metabolic syndrome, diabetes and obesity has been hampered due to contradictory findings on their potential safety. For example, while some reports show that ligand activation...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Girroir, Elizabeth E., Hollingshead, Holly E., Billin, Andrew N., Willson, Timothy M., Robertson, Gavin P., Sharma, Arun K., Amin, Shantu, Gonzalez, Frank J., Peters, Jeffrey M.
Format: Artigo
Idioma:Inglês
Publicat: 2007
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2278023/
https://ncbi.nlm.nih.gov/pubmed/18054822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tox.2007.10.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars